This research-use-only blend pairs a GHRH analog (CJC-1295, No DAC) with the GHSR agonist Ipamorelin to study dual-pathway GPCR signaling. Models explore pulsatile GH-axis dynamics, second-messenger responses, and combinatorial pathway effects in vitro. Not for diagnostic or therapeutic use.
- GHRH–GHSR signaling integration
- Pulse-driven pathway mapping
- Comparative analysis vs. single-agent controls
CJC-1295 (No DAC) + Ipamorelin | Molecular Identity & Composition
| General | |
| Name | CJC-1295 (No DAC) + Ipamorelin (RUO) |
| Component A — CJC-1295 (No DAC) | |
| Synonyms | Modified GRF (1-29) | CJC-1295 without DAC |
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | ≈3367.95 g/mol |
| CAS Number | 863288-34-0 |
| Component B — Ipamorelin | |
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | ≈711.9 g/mol |
| CAS Number | 170851-70-4 |
| Formulation & Handling | |
| Appearance | White to off-white lyophilized powder |
| Solubility | Soluble in sterile water or bacteriostatic water |
| Purity | ≥99% (HPLC) |
| Storage Guidelines | • Lyophilized: ≤0°F (–18°C), dry, protected from light • Reconstituted: 36–46°F (2–8°C); avoid repeat freeze–thaw • Long-Term: Keep dry and frozen until use |
Ellixon Bio Quality Advantage
- Purity & Identity: ≥99% | HPLC & MS validated
- Endotoxin & Sterility: <0.05 EU/mg | Third-party verified
- Stability & Process: Controlled nucleation lyophilization | Stability-focused procedures
- Formulation & QA: PhD-Formulated | GMP / ISO-Aligned manufacturing
- Packaging: Luxe Fridge-Ready Box
Category Overview | Signal Transduction Pathways
Signal transduction peptides are used in RUO studies to explore receptor engagement and downstream messaging. Dual-pathway designs enable analysis of synergy and pathway cross-talk in controlled systems.
Exciting Areas of Study
- GHRH–GHSR pathway integration
- Second-messenger kinetics and feedback
- Stress-model responses across cell types
- Benchmark combined vs. single-agent signaling
- Map pulsatile activation paradigms
CJC-1295 (No DAC) + Ipamorelin | Research Modeling & Applications
- Characterize dual-GPCR signaling and second-messenger outputs
- Profile GH-axis pulse shaping and feedback
- Assess synergy in co-stimulation paradigms
Research Use Disclaimer
This product is supplied for laboratory research use only (RUO) and is intended solely for qualified professionals in a controlled research setting. It is not a drug, food, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use or for any diagnostic, therapeutic, or clinical application. It is not for household use.
No statement on this page has been evaluated by the U.S. Food and Drug Administration. Nothing herein is intended to diagnose, treat, cure, or prevent any disease, nor to suggest any dosage, route, or method of administration. Ellixon Bio makes no representation or warranty, express or implied, regarding fitness for any purpose other than research and provides no medical or professional advice. The purchaser and end user assume full responsibility for safe handling, storage, and use in accordance with all applicable laws, regulations, and institutional safety protocols, and accept all associated risk and liability.
See our Terms & Conditions and our Research Compliance Disclaimers for complete terms.
